Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Histofy
Histofy is a UK-based company specializing in transparent AI solutions for computational pathology, focusing on tissue-based diagnostics and prognostics. Originating as a spin-out from the University…
Histofy
Histofy is a UK-based company specializing in transparent AI solutions for computational pathology, focusing on tissue-based diagnostics and prognostics. Originating as a spin-out from the University…
TL;DR
Founded: 2021 (University of Warwick spin-out)
Headquarters / Base: United Kingdom
Focus: Transparent AI for computational pathology (clinical diagnostics, prognostics, biopsy screening, pharma image analysis)
Flagship offerings: MitPro® (mitosis profiling); large bowel/colon biopsy screening AI
Notable investors / funding signals: Lumiares investment (Jul 2024); Source BioScience strategic investment (May 2025); NIHR grant (~£500K, Mar 2023)
≈11 employees
Company Overview
Problem Domain
Computational pathology: tissue image analytics for diagnostics, prognostics, biopsy screening and pharmaceutical research
Founded
2021
Industry
DeepTech
Tech Stack
Funding Track Record
£500K
NIHR-funded project to develop algorithms for endoscopic colon biopsy screening
Lumiares announced an investment alongside clinician co-investors
Strategic investment and partnership to explore integration and deployment of Histofy’s AI in pathology laboratories
Investor Signal
“Has received grant funding (NIHR) and strategic/VC investments (Lumiares; Source BioScience strategic investor)”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,300+
New This Week